Helping Independent Oncologists Thrive for Over 25 Years

Watch Now

Practice Stories

More than 2,700 providers across the nation have discovered the many benefits of joining The US Oncology Network. See why physicians are excited to be part of The Network, and learn how our oncology practice management solutions help them deliver value-based cancer care and achieve practice success.

Relationship Opportunities

We offer two models through which a practice can become part of The US Oncology Network to gain the many benefits our organization provides. Practices can choose the model that best meets their needs and goals.

Comprehensive Strategic Alliance (CSA)

In the comprehensive strategic alliance model, practices work with The Network to enable the success of the entire practice. Physicians maintain their independence, but get the support of a management company that has deep expertise in oncology practice management.

Learn More

Joint Venture (JV)

In the joint venture model, practices and The Network focus on the management of a radiation oncology center. Practices and McKesson Specialty Health each own a share of a radiation oncology asset and participate in the financial performance of that asset.

Learn More

When Crisis Strikes

In the oncology field, data and technology play crucial roles. The Network ensures that during high-stress systemic outages, dedicated teams are swiftly mobilized to restore technological tools and support daily operations, minimizing interruptions to patient care.

Learn how The Network practices are supported during a crisis.


Read the white paper here

2024 Annual Report

Discover how we’re empowering community practices with innovation, expert support, and a shared commitment to excellence in cancer care—today and for the future.


Download the 2024 Annual Report

"The Network has access to great tools, resources and support necessary to succeed under value-based contracts. The collaboration with a national spectrum of practices has been very important and will be even more so in the future."

J. Russell Hoverman, M.D.
Texas Oncology